Quality by Design is well known in the pharmaceutical industry. It is the initiative curated by the Food and Drug Administration (FDA) to ensure that the quality of a drug product is considered upfront in the product design phase and is continually evaluated and addressed throughout each subsequent phase. It is a key component of a Product Development Report and associated regulatory filing. So what is Drug Delivery by Design? It is the same philosophy in consideration of the desired drug delivery profile & patient experience. ARx’s drug delivery systems, soluble thin films and transdermal patches, have the unique ability to be tailored to achieve the intended release of the drug, whether it be for rapid onset or controlled release. With formulation options ranging from seconds to up to 7 days, each transdermal or thin film system can have multiple layers with different properties, drug loading, or therapeutic ingredients, making each product unique. Contact us to design your new product today.